Complications in fillers and Botox

Oral Maxillofac Surg Clin North Am. 2009 Feb;21(1):13-21, v. doi: 10.1016/j.coms.2008.11.001.

Abstract

Americans spent $11 billion on cosmetic surgery procedures in 2007. Almost $3 billion were spent on minimally invasive procedures, of which injectable facial fillers and botulinum toxin type A (Botox) were the most popular. Injectables have fueled the fires of the popularity of cosmetic facial surgery. They have provided more options to patients and surgeons and provided quick, affordable, predictable, and long-lasting improvement of facial wrinkles and lip augmentation. Even in sour economies, patients want to look good and although they may not have money to spend on surgical procedures, injectable treatments remain popular. This article addresses common complications of injectable fillers and Botox.

MeSH terms

  • Botulinum Toxins, Type A / administration & dosage*
  • Cosmetic Techniques / adverse effects
  • Dermatologic Agents / administration & dosage
  • Dermatologic Agents / adverse effects*
  • Face*
  • Humans
  • Hyaluronic Acid / administration & dosage
  • Hyaluronic Acid / adverse effects*
  • Injections, Intradermal / adverse effects
  • Postoperative Complications / classification*
  • Postoperative Complications / etiology
  • Postoperative Complications / prevention & control
  • Postoperative Complications / therapy
  • Rejuvenation
  • Skin / drug effects
  • Surgery, Plastic / adverse effects*
  • Surgery, Plastic / classification
  • Surgery, Plastic / methods

Substances

  • Dermatologic Agents
  • Hyaluronic Acid
  • Botulinum Toxins, Type A